Skip to content

Drug interactions

Linagliptin + Tecovirimat

Severity: Minor

Linagliptin and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat is a weak CYP3A4 inducer and could slightly reduce linagliptin levels. Tecovirimat courses are short, so the effect is likely small.

What this interaction means in plain words

Linagliptin and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Linagliptin belongs to Endocrine; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Weak induction of CYP3A4 by tecovirimat may modestly increase linagliptin metabolism.

What to do

No linagliptin adjustment is usually needed. Check blood glucose if hyperglycemia develops during treatment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Linagliptin with Tecovirimat?

MediHelp rates the interaction as minor. Linagliptin and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat is a weak CYP3A4 inducer and could slightly reduce linagliptin levels. Tecovirimat courses are short, so the effect is likely small.

How serious is the interaction between Linagliptin and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No linagliptin adjustment is usually needed. Check blood glucose if hyperglycemia develops during treatment.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in